Chemoprevention of glucocorticoids for pulmonary carcinogenesis_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

LI Hongtao ,  ZHANG Tiantuo

Department of Respiratory Medicine, The Third Affiliated Hospital of Sun Yat-sen University. Guangzhou, Guangdong,510630, China;

Corresponding?author：

ZHANG Tiantuo, Email: zhtituli@163.com

Keywords：

糖皮質激素; 肺癌; 化學預防

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

肺癌是全球范圍內腫瘤致死的最常見原因，其死亡率超過了結腸癌、乳腺癌和前列腺癌之和[1]。雖然肺癌已成為全球最主要的死因之一，然而在其治療方面仍然缺乏根本有效的方法。腫瘤的化學預防（chemoprevention）是一項有效的措施[2]，其含義是：應用天然或人工合成化合物阻斷、逆轉或預防侵襲性腫瘤的發生，降低具有侵襲性或有臨床表現的癌癥的發生率。腫瘤化學預防藥物研究已成為目前腫瘤學和藥學的研究熱點之一。

Citation： LI Hongtao,ZHANG Tiantuo. Chemoprevention of glucocorticoids for pulmonary carcinogenesis. Chinese Journal of Respiratory and Critical Care Medicine, 2008, 08(3): 230-233. doi: Copy

1.	Jemal A，Tiwari RC，Murray T，et al.Cancer statistics，2004.CA Cancer J Clin，2004，54：8-29.
2.	Shureiqi I，Reddy P，Brenner DE.Chemoprevention：general perspective.Crit Rev Oncol Hematol，2000，33：157-167.
3.	Shacter E，Weitzman SA.Chronic inflammation and cancer.Oncology (Williston Park)，2002，16：217-226，229.
4.	Brower V.Feeding the flame：new research adds to role of inflammation in cancer development.J Natl Cancer Inst，2005，97：251-253.
5.	Il’yasova D，Colbert LH，Harris TB，et al.Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort.Cancer Epidemiol Biomarkers Prev，2005，14：2413-2418.
6.	Malkinson AM.Role of inflammation in mouse lung tumorigenesis：a review.Exp Lung Res，2005，31：57-82.
7.	Petty TL.Are COPD and lung cancer two manifestations of the same disease? Chest，2005，128：1895-1897.
8.	Lapperre TS，Postma DS，Gosman MM，et al.Relation between duration of smoking cessation and bronchial inflammation in COPD.Thorax，2006，61：115-121.
9.	Willemse BW，ten Hacken NH，Rutgers B，et al.Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers.Eur Respir J，2005，26：835-845.
10.	Hogg JC，Chu F，Utokaparch S，et al.The nature of small-airway obstruction in chronic obstructive pulmonary disease.N Engl J Med，2004，350：2645-2653.
11.	Brody JS，Spira A.State of the art.Chronic obstructive pulmonary disease，inflammation，and lung cancer.Proc Am Thorac Soc.，2006，3：535-537.
12.	Komarova EA，Krivokrysenko V，Wang K，et al.p53 is a suppressor of inflammatory response in mice.FASEB J，2005，19：1030-1032.
13.	Littman AJ，Jackson LA，Vaughan TL.Chlamydia pneumoniae and lung cancer：epidemiologic evidence.Cancer Epidemiol Biomarkers Prev，2005，14：773-778.
14.	Kocazeybek B.Chronic Chlamydophila pneumoniae infection in lung cancer，a risk factor：a case-control study.J Med Microbiol，2003，52：721-726.
15.	Veglia F，Vineis P，Overvad K，et al.Occupational exposures，environmental tobacco smoke，and lung cancer.Epidemiology，2007，18：769-775.
16.	Pagès V，Fuchs RP.How DNA lesions are turned into mutations within cells? Oncogene，2002，21：8957-8966.
17.	Sadowska AM，van Overveld FJ，Górecka D，et al.The interrelationship between markers of inflammation and oxidative stress in chronic obstructive pulmonary disease：modulation by inhaled steroids and antioxidant.Respir Med，2005，99：241-249.
18.	Sin DD，Lacy P，York E，et al.Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease.Am J Respir Crit Care Med，2004，170：760-765.
19.	Lam S，leRiche JC，McWilliams A，et al.A randomized phase IIb trial of pulmicort turbuhaler (budesonide) in people with dysplasia of the bronchial epithelium.Clin Cancer Res，2004，10：6502-6511.
20.	Parimon T，Chien JW，Bryson CL，et al.Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease.Am J Respir Crit Care Med，2007，175：712-719.
21.	Yao R，Wang Y，Lemon WJ，et al.Budesonide exerts its chemopreventive efficacy during mouse lung tumorigenesis by modulating gene expressions.Oncogene，2004，23：7746-7752.
22.	Greenstein S，Ghias K，Krett NL，et al.Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies.Clin Cancer Res，2002，8：1681-1694.
23.	Pereira MA，Li Y，Gunning WT，et al.Prevention of mouse lung tumors by budesonide and its modulation of biomarkers.Carcinogenesis，2002，23：1185-1192.
24.	Bai F，Matsui T，Ohtani-Fujita N，et al.Promoter activation and following induction of the p21/WAF1 gene by flavone is involved in G1 phase arrest in A549 lung adenocarcinoma cells.FEBS Lett，1998，437：61-64.
25.	Tsukamoto S，Sugio K，Sakada T，et al.Reduced expression of cell-cycle regulator p27(Kip1) correlates with a shortened survival in non-small cell lung cancer.Lung Cancer，2001，34：83-90.
26.	Greenberg AK，Hu J，Basu S，et al.Glucocorticoids inhibit lung cancer cell growth through both the extracellular signal-related kinase pathway and cell cycle regulators.Am J Respir Cell Mol Biol，2002，27：320-328.
27.	Spierings D，McStay G，Saleh M，et al.Connected to death：the (unexpurgated) mitochondrial pathway of apoptosis.Science，2005，310：66-67.
28.	Herzog CR，Lubet RA，You M.Genetic alterations in mouse lung tumors：implications for cancer chemoprevention.J Cell Biochem，1997，29：49-63.
29.	Wattenberg LW，Wiedmann TS，Estensen RD，et al.Chemoprevention of pulmonary carcinogenesis by brief exposures to aerosolized budesonide or beclomethasone dipropionate and by the combination of aerosolized budesonide and dietary myo-inositol.Carcinogenesis，2000，21：179-182.
30.	Wistuba II，Mao L，Gazdar AF.Smoking molecular damage in bronchial epithelium.Oncogene，2002，21：7298-7306.
31.	Patel R，Garg R，Erande S，et al.Chemopreventive herbal anti-oxidants：current status and future perspectives.J Chin Biochem Nutr，2007，40：82-91.
32.	Estensen RD，Jordan MM，Wiedmann TS，et al.Effect of chemopreventive agents on separate stages of progression of benzo[alpha]pyrene induced lung tumors in A/J mice.Carcinogenesis，2004，25：197-201.

1. Jemal A，Tiwari RC，Murray T，et al.Cancer statistics，2004.CA Cancer J Clin，2004，54：8-29.
2. Shureiqi I，Reddy P，Brenner DE.Chemoprevention：general perspective.Crit Rev Oncol Hematol，2000，33：157-167.
3. Shacter E，Weitzman SA.Chronic inflammation and cancer.Oncology (Williston Park)，2002，16：217-226，229.
4. Brower V.Feeding the flame：new research adds to role of inflammation in cancer development.J Natl Cancer Inst，2005，97：251-253.
5. Il’yasova D，Colbert LH，Harris TB，et al.Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort.Cancer Epidemiol Biomarkers Prev，2005，14：2413-2418.
6. Malkinson AM.Role of inflammation in mouse lung tumorigenesis：a review.Exp Lung Res，2005，31：57-82.
7. Petty TL.Are COPD and lung cancer two manifestations of the same disease? Chest，2005，128：1895-1897.
8. Lapperre TS，Postma DS，Gosman MM，et al.Relation between duration of smoking cessation and bronchial inflammation in COPD.Thorax，2006，61：115-121.
9. Willemse BW，ten Hacken NH，Rutgers B，et al.Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers.Eur Respir J，2005，26：835-845.
10. Hogg JC，Chu F，Utokaparch S，et al.The nature of small-airway obstruction in chronic obstructive pulmonary disease.N Engl J Med，2004，350：2645-2653.
11. Brody JS，Spira A.State of the art.Chronic obstructive pulmonary disease，inflammation，and lung cancer.Proc Am Thorac Soc.，2006，3：535-537.
12. Komarova EA，Krivokrysenko V，Wang K，et al.p53 is a suppressor of inflammatory response in mice.FASEB J，2005，19：1030-1032.
13. Littman AJ，Jackson LA，Vaughan TL.Chlamydia pneumoniae and lung cancer：epidemiologic evidence.Cancer Epidemiol Biomarkers Prev，2005，14：773-778.
14. Kocazeybek B.Chronic Chlamydophila pneumoniae infection in lung cancer，a risk factor：a case-control study.J Med Microbiol，2003，52：721-726.
15. Veglia F，Vineis P，Overvad K，et al.Occupational exposures，environmental tobacco smoke，and lung cancer.Epidemiology，2007，18：769-775.
16. Pagès V，Fuchs RP.How DNA lesions are turned into mutations within cells? Oncogene，2002，21：8957-8966.
17. Sadowska AM，van Overveld FJ，Górecka D，et al.The interrelationship between markers of inflammation and oxidative stress in chronic obstructive pulmonary disease：modulation by inhaled steroids and antioxidant.Respir Med，2005，99：241-249.
18. Sin DD，Lacy P，York E，et al.Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease.Am J Respir Crit Care Med，2004，170：760-765.
19. Lam S，leRiche JC，McWilliams A，et al.A randomized phase IIb trial of pulmicort turbuhaler (budesonide) in people with dysplasia of the bronchial epithelium.Clin Cancer Res，2004，10：6502-6511.
20. Parimon T，Chien JW，Bryson CL，et al.Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease.Am J Respir Crit Care Med，2007，175：712-719.
21. Yao R，Wang Y，Lemon WJ，et al.Budesonide exerts its chemopreventive efficacy during mouse lung tumorigenesis by modulating gene expressions.Oncogene，2004，23：7746-7752.
22. Greenstein S，Ghias K，Krett NL，et al.Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies.Clin Cancer Res，2002，8：1681-1694.
23. Pereira MA，Li Y，Gunning WT，et al.Prevention of mouse lung tumors by budesonide and its modulation of biomarkers.Carcinogenesis，2002，23：1185-1192.
24. Bai F，Matsui T，Ohtani-Fujita N，et al.Promoter activation and following induction of the p21/WAF1 gene by flavone is involved in G1 phase arrest in A549 lung adenocarcinoma cells.FEBS Lett，1998，437：61-64.
25. Tsukamoto S，Sugio K，Sakada T，et al.Reduced expression of cell-cycle regulator p27(Kip1) correlates with a shortened survival in non-small cell lung cancer.Lung Cancer，2001，34：83-90.
26. Greenberg AK，Hu J，Basu S，et al.Glucocorticoids inhibit lung cancer cell growth through both the extracellular signal-related kinase pathway and cell cycle regulators.Am J Respir Cell Mol Biol，2002，27：320-328.
27. Spierings D，McStay G，Saleh M，et al.Connected to death：the (unexpurgated) mitochondrial pathway of apoptosis.Science，2005，310：66-67.
28. Herzog CR，Lubet RA，You M.Genetic alterations in mouse lung tumors：implications for cancer chemoprevention.J Cell Biochem，1997，29：49-63.
29. Wattenberg LW，Wiedmann TS，Estensen RD，et al.Chemoprevention of pulmonary carcinogenesis by brief exposures to aerosolized budesonide or beclomethasone dipropionate and by the combination of aerosolized budesonide and dietary myo-inositol.Carcinogenesis，2000，21：179-182.
30. Wistuba II，Mao L，Gazdar AF.Smoking molecular damage in bronchial epithelium.Oncogene，2002，21：7298-7306.
31. Patel R，Garg R，Erande S，et al.Chemopreventive herbal anti-oxidants：current status and future perspectives.J Chin Biochem Nutr，2007，40：82-91.
32. Estensen RD，Jordan MM，Wiedmann TS，et al.Effect of chemopreventive agents on separate stages of progression of benzo[alpha]pyrene induced lung tumors in A/J mice.Carcinogenesis，2004，25：197-201.

Previous Article
Testing Treatments –– Better Research for Better Healthcare

Chinese Journal of Respiratory and Critical Care Medicine

Chemoprevention of glucocorticoids for pulmonary carcinogenesis

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Format

Content